Table of Contents

Select this article
- Y Chern,
- J Y Chiou,
- H L Lai,
- and M H Tsai
Regulation of adenylyl cyclase type VI activity during desensitization of the A2a adenosine receptor-mediated cyclic AMP response: role for protein phosphatase 2A.
Mol Pharmacol July 1995 48:1-8
- Abstract
- Full Text (PDF)
Select this article
- G Weng,
- F Yee,
- P Michl,
- D Reis,
- and C Wahlestedt
Studies on neuropeptide Y receptors in a mouse adrenocortical cell line.
Mol Pharmacol July 1995 48:9-14
- Abstract
- Full Text (PDF)
Select this article
- H J Prochaska,
- W G Bornmann,
- P Baron,
- and B Polsky
Inhibition of human immunodeficiency virus type 1 replication by 7-methyl-6,8-bis(methylthio)pyrrolo[1,2-a]pyrazine, an in vivo metabolite of oltipraz.
Mol Pharmacol July 1995 48:15-20
- Abstract
- Full Text (PDF)
Select this article
- C Borchers,
- W R Ulrich,
- K Klemm,
- W Ise,
- V Gekeler,
- S Haas,
- A Schödl,
- J Conrad,
- M Przybylski,
- and R Boer
B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoprotein.
Mol Pharmacol July 1995 48:21-29
- Abstract
- Full Text (PDF)
Select this article
- P De Isabella,
- M Palumbo,
- C Sissi,
- G Capranico,
- N Carenini,
- E Menta,
- A Oliva,
- S Spinelli,
- A P Krapcho,
- and F C Giuliani
Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives.
Mol Pharmacol July 1995 48:30-38
- Abstract
- Full Text (PDF)
Select this article
- C C Chen,
- J Chang,
- and W C Chen
Role of protein kinase C subtypes alpha and delta in the regulation of bradykinin-stimulated phosphoinositide breakdown in astrocytes.
Mol Pharmacol July 1995 48:39-47
- Abstract
- Full Text (PDF)
Select this article
- R E Link,
- M S Stevens,
- M Kulatunga,
- M Scheinin,
- G S Barsh,
- and B K Kobilka
Targeted inactivation of the gene encoding the mouse alpha 2c-adrenoceptor homolog.
Mol Pharmacol July 1995 48:48-55
- Abstract
- Full Text (PDF)
Select this article
- S Cavallaro,
- V D'Agata,
- V Guardabasso,
- S Travali,
- F Stivala,
- and P L Canonico
Differentiation induces pituitary adenylate cyclase-activating polypeptide receptor expression in PC-12 cells.
Mol Pharmacol July 1995 48:56-62
- Abstract
- Full Text (PDF)
Select this article
- J F Margiotta and
- D Pardi
Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity.
Mol Pharmacol July 1995 48:63-71
- Abstract
- Full Text (PDF)
Select this article
- R T Reilly,
- K W Barbour,
- R B Dunlap,
- and F G Berger
Biphasic binding of 5-fluoro-2'-deoxyuridylate to human thymidylate synthase.
Mol Pharmacol July 1995 48:72-79
- Abstract
- Full Text (PDF)
Select this article
- P A Glascott, Jr,
- E Gilfor,
- and J L Farber
Relationship of the metabolism of vitamins C and E in cultured hepatocytes treated with tert-butyl hydroperoxide.
Mol Pharmacol July 1995 48:80-88
- Abstract
- Full Text (PDF)
Select this article
- B Rehberg,
- E Bennett,
- Y H Xiao,
- S R Levinson,
- and D S Duch
Voltage- and frequency-dependent pentobarbital suppression of brain and muscle sodium channels expressed in a mammalian cell line.
Mol Pharmacol July 1995 48:89-97
- Abstract
- Full Text (PDF)
Select this article
- R J Hill,
- A M Grant,
- W Volberg,
- L Rapp,
- C Faltynek,
- D Miller,
- K Pagani,
- E Baizman,
- S Wang,
- and J W Guiles
WIN 17317-3: novel nonpeptide antagonist of voltage-activated K+ channels in human T lymphocytes.
Mol Pharmacol July 1995 48:98-104
- Abstract
- Full Text (PDF)
Select this article
- D R Groebe,
- J M Dumm,
- E S Levitan,
- and S N Abramson
alpha-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors.
Mol Pharmacol July 1995 48:105-111
- Abstract
- Full Text (PDF)
Select this article
- L M Winn and
- P G Wells
Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity.
Mol Pharmacol July 1995 48:112-120
- Abstract
- Full Text (PDF)
Select this article
- P F Méry,
- C Pavoine,
- F Pecker,
- and R Fischmeister
Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes.
Mol Pharmacol July 1995 48:121-130
- Abstract
- Full Text (PDF)
Select this article
- T M Piser,
- R A Lampe,
- R A Keith,
- and S A Thayer
Omega-grammotoxin SIA blocks multiple, voltage-gated, Ca2+ channel subtypes in cultured rat hippocampal neurons.
Mol Pharmacol July 1995 48:131-139
- Abstract
- Full Text (PDF)
Select this article
- P A Johansen,
- L A Chase,
- A D Sinor,
- J F Koerner,
- R L Johnson,
- and M B Robinson
Type 4a metabotropic glutamate receptor: identification of new potent agonists and differentiation from the L-(+)-2-amino-4-phosphonobutanoic acid-sensitive receptor in the lateral perforant pathway in rats.
Mol Pharmacol July 1995 48:140-149
- Abstract
- Full Text (PDF)
Select this article
- J Labrecque,
- A Fargin,
- M Bouvier,
- P Chidiac,
- and M Dennis
Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells.
Mol Pharmacol July 1995 48:150-159
- Abstract
- Full Text (PDF)
Select this article
- J A Yao,
- N C Saxena,
- M R Ziai,
- S Ling,
- and G N Tseng
Effects of n-dodecylguanidine on A-type potassium channels: role of external surface charges in channel gating.
Mol Pharmacol July 1995 48:160-171
- Abstract
- Full Text (PDF)

Regulation of adenylyl cyclase type VI activity during desensitization of the A2a adenosine receptor-mediated cyclic AMP response: role for protein phosphatase 2A.

Studies on neuropeptide Y receptors in a mouse adrenocortical cell line.

Inhibition of human immunodeficiency virus type 1 replication by 7-methyl-6,8-bis(methylthio)pyrrolo[1,2-a]pyrazine, an in vivo metabolite of oltipraz.

B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoprotein.

Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives.

Role of protein kinase C subtypes alpha and delta in the regulation of bradykinin-stimulated phosphoinositide breakdown in astrocytes.

Targeted inactivation of the gene encoding the mouse alpha 2c-adrenoceptor homolog.

Differentiation induces pituitary adenylate cyclase-activating polypeptide receptor expression in PC-12 cells.

Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity.

Biphasic binding of 5-fluoro-2'-deoxyuridylate to human thymidylate synthase.

Relationship of the metabolism of vitamins C and E in cultured hepatocytes treated with tert-butyl hydroperoxide.

Voltage- and frequency-dependent pentobarbital suppression of brain and muscle sodium channels expressed in a mammalian cell line.

WIN 17317-3: novel nonpeptide antagonist of voltage-activated K+ channels in human T lymphocytes.

alpha-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors.

Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity.

Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes.

Omega-grammotoxin SIA blocks multiple, voltage-gated, Ca2+ channel subtypes in cultured rat hippocampal neurons.

Type 4a metabotropic glutamate receptor: identification of new potent agonists and differentiation from the L-(+)-2-amino-4-phosphonobutanoic acid-sensitive receptor in the lateral perforant pathway in rats.

Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells.

Effects of n-dodecylguanidine on A-type potassium channels: role of external surface charges in channel gating.

This Issue

Current Issue